Zhong A - Search Results

1

COPS5 Conferred the Platinum Resistance in Epithelial Ovarian Cancer.

Zhang H, Yan T, Zhong A, Guo L, Lu R. Zhang H, et al. Among authors: zhong a. Curr Issues Mol Biol. 2022 Sep 1;44(9):3948-3958. doi: 10.3390/cimb44090271. Curr Issues Mol Biol. 2022. PMID: 36135183 Free PMC article.

2

COPS5 inhibition arrests the proliferation and growth of serous ovarian cancer cells via the elevation of p27 level.

Zhang H, Zhong A, Sun J, Chen M, Xie S, Zheng H, Wang Y, Yu Y, Guo L, Lu R. Zhang H, et al. Among authors: zhong a. Biochem Biophys Res Commun. 2017 Nov 4;493(1):85-93. doi: 10.1016/j.bbrc.2017.09.070. Epub 2017 Sep 15. Biochem Biophys Res Commun. 2017. PMID: 28919423

3

Inhibition of MUS81 improves the chemical sensitivity of olaparib by regulating MCM2 in epithelial ovarian cancer.

Zhong A, Zhang H, Xie S, Deng M, Zheng H, Wang Y, Chen M, Lu R, Guo L. Zhong A, et al. Oncol Rep. 2018 Apr;39(4):1747-1756. doi: 10.3892/or.2018.6229. Epub 2018 Jan 22. Oncol Rep. 2018. PMID: 29393493

4

Establishment of a detection assay for DNA endonuclease activity and its application in the screening and prognosis of malignant lymphoma.

Lu R, Wang Y, Xu X, Xie S, Wang Y, Zhong A, Zheng H, Yu Y, Gao X, Guo L. Lu R, et al. Among authors: zhong a. BMC Biochem. 2018 Jul 31;19(1):6. doi: 10.1186/s12858-018-0096-6. BMC Biochem. 2018. PMID: 30064372 Free PMC article.

5

Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.

Chen M, Zhang H, Zhang G, Zhong A, Ma Q, Kai J, Tong Y, Xie S, Wang Y, Zheng H, Guo L, Lu R. Chen M, et al. Among authors: zhong a. Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):74-82. doi: 10.1016/j.bbrc.2018.10.164. Epub 2018 Nov 16. Biochem Biophys Res Commun. 2018. PMID: 30454896

6

Elevated serum HER-2 predicts poor prognosis in breast cancer and is correlated to ADAM10 expression.

Zheng H, Zhong A, Xie S, Wang Y, Sun J, Zhang J, Tong Y, Chen M, Zhang G, Ma Q, Kai J, Guo L, Lu R. Zheng H, et al. Among authors: zhong a. Cancer Med. 2019 Feb;8(2):679-685. doi: 10.1002/cam4.1859. Epub 2019 Jan 19. Cancer Med. 2019. PMID: 30661303 Free PMC article.

7

Diagnostic Significance of Serum IgG Galactosylation in CA19-9-Negative Pancreatic Carcinoma Patients.

Zhong A, Qin R, Qin W, Han J, Gu Y, Zhou L, Zhang H, Ren S, Lu R, Guo L, Gu J. Zhong A, et al. Front Oncol. 2019 Feb 27;9:114. doi: 10.3389/fonc.2019.00114. eCollection 2019. Front Oncol. 2019. PMID: 30873386 Free PMC article.

8

Molecular profiling of mucinous epithelial ovarian cancer by weighted gene co-expression network analysis.

Zhang GH, Chen MM, Kai JY, Ma Q, Zhong AL, Xie SH, Zheng H, Wang YC, Tong Y, Lu RQ, Guo L. Zhang GH, et al. Gene. 2019 Aug 15;709:56-64. doi: 10.1016/j.gene.2019.05.034. Epub 2019 May 17. Gene. 2019. PMID: 31108164

9

MUS81 Inhibition Increases the Sensitivity to Therapy Effect in Epithelial Ovarian Cancer via Regulating CyclinB Pathway.

Zhong A, Zheng H, Zhang H, Sun J, Shen J, Deng M, Chen M, Lu R, Guo L. Zhong A, et al. J Cancer. 2019 May 21;10(10):2276-2287. doi: 10.7150/jca.30818. eCollection 2019. J Cancer. 2019. PMID: 31258731 Free PMC article.

10

Inhibition of MCM2 enhances the sensitivity of ovarian cancer cell to carboplatin.

Deng M, Sun J, Xie S, Zhen H, Wang Y, Zhong A, Zhang H, Lu R, Guo L. Deng M, et al. Among authors: zhong a. Mol Med Rep. 2019 Sep;20(3):2258-2266. doi: 10.3892/mmr.2019.10477. Epub 2019 Jul 9. Mol Med Rep. 2019. PMID: 31322224 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

472 results

Search Page

Filters